A critical advance in cancer investigation is arising with the use of mini-antibodies to re-engage dysfunctional p53. This crucial tumor protector protein is frequently inactivated in various types of tumors, resulting https://mediasocially.com/story6927138/mini-antibodies-restore-the-p53-protein-the-potential-hope-for-tumor-treatment